IceCure Medical Ltd
ICCM
$1.01
$0.127214.41%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -48.07% | -30.28% | 7.90% | 4.65% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -48.07% | -30.28% | 7.90% | 4.65% | |
| Cost of Revenue | -18.09% | -33.24% | -4.37% | 21.54% | |
| Gross Profit | -75.28% | -26.71% | 22.12% | -15.94% | |
| SG&A Expenses | -16.94% | 54.55% | -10.80% | -9.14% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -7.76% | 15.63% | -15.52% | -5.87% | |
| Operating Income | -4.86% | -32.50% | 20.90% | 7.76% | |
| Income Before Tax | -9.19% | -49.55% | 20.78% | 4.22% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -9.19% | -49.55% | 20.78% | 4.22% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -9.19% | -49.55% | 20.78% | 4.22% | |
| EBIT | -4.86% | -32.50% | 20.90% | 7.76% | |
| EBITDA | -5.63% | -33.34% | 21.39% | 8.07% | |
| EPS Basic | 8.90% | -21.95% | 26.17% | 6.54% | |
| Normalized Basic EPS | 8.91% | -21.95% | 26.27% | -- | |
| EPS Diluted | 8.90% | -21.95% | 26.17% | 6.54% | |
| Normalized Diluted EPS | 8.91% | -21.95% | 26.27% | -- | |
| Average Basic Shares Outstanding | 19.82% | 22.62% | 7.33% | 2.44% | |
| Average Diluted Shares Outstanding | 19.82% | 22.62% | 7.33% | 2.44% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |